New Drug Shows Promise for Functional Cure of Hepatitis B in Clinical Trial

A recent third clinical trial of a new drug for Hepatitis B demonstrated that approximately 19 percent of participants achieved a functional cure. This development offers hope for improved treatment outcomes for patients with Hepatitis B. The findings mark a significant step in ongoing efforts to manage and potentially cure the disease.

Originally published by gnews